176 filings
Page 3 of 9
8-K
d0s3kuq b6
30 Mar 21
Results of Operations and Financial Condition
7:40am
8-K
rqnd8ao59jlna u4aw
30 Mar 21
Entry into a Material Definitive Agreement
7:16am
8-K
8tmlr9 qoh3wbo61
25 Mar 21
Entry into a Material Definitive Agreement
8:51am
8-K
akxxhj
15 Dec 20
Investor Presentation December 2020
8:35am
8-K
7zpb 3hdm2
4 Nov 20
Results of Operations and Financial Condition
7:01am
8-K
y1uth 6doq1kqo0e2awp
21 Sep 20
PRS-343 Esmo Update September 2020
11:06am
8-K
2v0v00ikk dn
21 Sep 20
Regulation FD Disclosure
7:56am
8-K
7ey40z9j7m 6orovq61l
9 Sep 20
Investor Presentation September 2020
9:14am
8-K
uc1mbal2tzn1fnj
10 Aug 20
Pieris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:45am
8-K
xxh4nceevdknlhf
10 Aug 20
Entry into a Material Definitive Agreement
7:40am
8-K
8w7armbqvvv47 nu
20 Jul 20
Pieris Pharmaceuticals Announces Partial Clinical Hold on PRS-343
4:12pm
8-K
66cghrrlq
29 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
lauzdjn
8 Jun 20
Other Events
5:19pm
8-K
v6o7lbw8ovoy qq
4 Jun 20
Investor Presentation June 2020
3:26pm
8-K
s8c42cj9jvgskv
21 May 20
Investor Presentation May 2020
10:10am
8-K
43wc6r9vbair u9me0
11 May 20
Results of Operations and Financial Condition
7:15am
8-K
1ulw6v 2laf6
6 Apr 20
Entry into a Material Definitive Agreement
4:11pm
8-K
xdft8 r35vjy1zc
24 Mar 20
Other Events
12:00am
8-K
ngw7i
12 Mar 20
Results of Operations and Financial Condition
7:39am
8-K
susbpjahzzjmwx1o
28 Feb 20
Regulation FD Disclosure
10:59am